ArticleFrontiers in surgery2026
Case Report: Neoadjuvant FOLFOXIRI followed by laparoscopic en bloc resection and psoas hitch reconstruction for locally advanced colorectal cancer with suspected ureteral invasion: a three-case series.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radical resection is essential for achieving R0 resection and improving prognosis in patients with locally advanced colorectal cancer (CRC) involving adjacent organs. When combined ureteral resection is required, urinary tract reconstruction is critical, as it influences both the risk of complications and postoperative quality of life. Here, we report three cases of locally advanced CRC with suspected ureteral invasion, treated with neoadjuvant chemotherapy (NAC) followed by laparoscopic tumor resection and ureteral reconstruction using the psoas hitch technique, which avoids the use of intestinal segments. Three patients with locally advanced CRC and suspected ureteral involvement received six cycles of FOLFOXIRI-based neoadjuvant chemotherapy (with panitumumab added in one patient). After significant tumor shrinkage, laparoscopic radical resection, including combined ureteral resection, was performed. Ureteroneocystostomy was carried out under direct vision through a lower transverse (Pfannenstiel) incision. Operative times ranged from 505 to 727 min, with no major complications. Postoperative histopathology revealed ypT3N0M0, ypT3N1aM0, and ypT4bN1bM0, respectively, with no pathological evidence of ureteral invasion. All patients received adjuvant chemotherapy and remain recurrence-free to date. Renal function was preserved postoperatively in all cases. We describe three cases in which neoadjuvant chemotherapy effectively shrank locally advanced CRC, yet combined ureteral resection was still necessary to ensure a secure R0 resection. Our approach enabled curative resection while preserving renal function and allowing for the timely initiation of adjuvant chemotherapy. When appropriate cases are selected, the psoas hitch technique can be a feasible and safe method for ureteral reconstruction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.